Rapid disease progression in human immunodeficiency virus type 1- infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis

Clinical Infectious Diseases

Volumn 24, Issue 5, 1997, Pages 936-941

  Veenstra, Jan ^a   Veugelers, Paul J ^b   Keet, Ireneus P M ^b   Van Der Ven, Andre J A M ^b   Miedema, Frank ^b   Lange, Joep M A ^b   Coutinho, Roel A ^b  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADULT; ARTICLE; DISEASE COURSE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RASH; TOXOPLASMOSIS;

EID: 0030986105     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.5.936     Document Type: Article

References (18)

1. Hughes W, Leoung G, Kramer F, et al. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome (AIDS). N Engl J Med 1993;328:1521-7.
2. Schneider MME, Hoepelman AIM, Eeftinck Schattenkerk JKM, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992;327:1836-41.
3. Hardy WD, Feinberg J, Finkelstein DM, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: AIDS clinical trials group protocol 021. N Engl J Med 1992;327:1842-8.
4. Ruskin J, LaRiviere M. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 1991;337:468-71.
5. Carr A, Tindall B, Brew BJ, et al. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992;117:106-11.
6. Schneider MME, Nielsen TL, Nelsing S, et al. Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. J Infect Dis 1995;171:1632-6.
7. 3: a cost-effectiveness analysis. J Acquir Immune Defic Syndr 1991;4:521-31.
8. Castellano AR, Nettleman MD. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia. JAMA 1991;266:820-4.
9. + cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 1988;158:615-22.
10. Mulder JW, Cooper DA, Mathiesen L, et al. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017). AIDS 1994;8:313-21.
11. Centers for Disease Control. Revision of the case definition of acquired immune deficiency syndrome. MMWR Mortal Morb Wkly Rep 1987;36(suppl):1S-15S.
12. Roos MIL, Miedema F, Koot M, et al. T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J Infect Dis 1995;171:531-6.
13. + cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
14. Koot M, Vos AH, Keet IPM, et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.
15. May T, Beuscart C, Reynes J, et al. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized controlled clinical trial. J Acquir Immune Defic Syndr 1994;7:457-62.
16. + lymphocyte count. J Infect Dis 1993;168:314-7.
17. Battegay M, Opravil M, Wüthrich B, Luthy R. Rash with amoxicillin-clavulanate therapy in HIV-infected patients. Lancet 1989;2:1100.
18. Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis 1993;167:180-5.